R

Regulaxis SAS

6 employees

Regulaxis is focused in research, development and licensing of human innovative synthetic molecules for high unmet medical needs

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Cancer
Acromegaly
Osteoarthritis
Health Care

Date founded

2013

Funding rounds raised

Total raised

$2.4M

from 1 investors over 1 rounds

R

Regulaxis SAS raised $2.4M on June 1, 2017

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ